Westerville, Ohio - According to SSTI, last week, the Biden-Harris administration released an initial budget proposal for FY 2022 discretionary appropriations. The document (referred to in Washington as a “skinny budget,” not because of the overall size of spending but because it serves as more of an outline or framework for the full budget proposal which will come in May) clearly emphasizes the importance of climate change, economic opportunity, equity and health as cross-cutting priorities. For regional innovation economies, these priorities would translate into significant increases in R&D funding, as well as additional funds for tech-based economic development activities.
Trenton, New Jersey - According to the New Jersey Economic Development Authority, its board of directors has approved the reopening of the 21st Century Redevelopment Program, which had been put on hold in April 2020 due to the COVID-19 pandemic. The program makes grants up to $50,000 available to suburban communities to help them redevelop, repurpose, or regreen vacant and underutilized retail or office park properties.
“The 21st Century Redevelopment Program will play an important role in Governor Murphy’s plan for a stronger, fairer recovery from the COVID-19 pandemic by providing resources to help municipalities repurpose dormant office spaces and industrial parks into valuable community assets,” said NJEDA Chief Executive Officer Tim Sullivan. “This has always been necessary, but it is an even better opportunity now as communities adjust to the post-pandemic future of work and the changes in demand for office and retail space that will come with it.”
Washington D.C. - According to PHRMA, on April 3, more than four million Americans received a COVID-19 vaccine — the largest single-day vaccination event in human history. For innovators across the pharmaceutical industry, these moments make the years — sometimes decades — of painstaking trial and error worth it.I’m incredibly proud of our industry’s role in combating this pandemic. At the same time, our battle against COVID-19 has driven home an important reality: We need to build a better health care system that ensures scientific advances are accessible and affordable to everyone who needs them.
Princeton branch of prestigious Ludwig Cancer Institute will make diet — and metabolism — its top research priority
Princeton, New Jersey - According to ROI, these are things to ponder during cancer research.
NJEDA Announces Launch Dates for $85 Million Phase 4 of The Small Business Emergency Assistance Grant Program
Trenton, New Jersey - According to the New Jersey Economic Development Authority, it announced Phase 4 of the Authority’s Small Business Emergency Assistance Grant Program, adding $85 million in funds from the Coronavirus Aid, Relief, and Economic Security (CARES) Act. Phase 4 will provide short-term operating support to a broad group of New Jersey small and medium sized businesses and non-profits that have been negatively impacted during the declared state of emergency. More information is available here. Interested business owners will need to pre-register here to access the application. Pre-registration will begin on Monday, April 19, 2021 at 9:00 a.m. and will close on April 29, 2021 at 5:00 p.m. The application will be available via a phased approach following the end of the pre-registration period, as detailed below. Applicants must complete the full application to be considered for grant funding.
Princeton, New Jersey - According to ROI, Princeton University will be the home of a new branch of the Ludwig Institute for Cancer Research, an international community of distinguished scientists dedicated to preventing and controlling cancer, officials from Princeton and the Ludwig Institute announced Tuesday morning.
The Ludwig Princeton branch will focus on cancer metabolism and its promise for new and better ways to prevent and treat cancer.
The clinical translation of research at the Ludwig Princeton Branch will be conducted in the tristate region, including in partnership with RWJBarnabas Health and Rutgers Cancer Institute of New Jersey — the state’s only National Cancer Institute-designated Comprehensive Cancer Center and a consortium cancer center between Rutgers University and Princeton University.
ICYMI: New CBO Report highlights biopharmaceutical leadership in the development of new treatments and cures
Washington D.C. - According to PHRMA, America’s biopharmaceutical companies are at the heart of a research and development (R&D) ecosystem that develops more innovative medicines than any other country in the world. The ongoing development of new, life-saving and life-improving medicines, including those for COVID-19, would not be possible without the robust investment, scientific expertise and manufacturing capabilities from biopharmaceutical research companies.In recent years, rapid advances in scientific discovery have ushered in a new era of medicine, transforming our ability to treat, and in some cases cure, some of the most challenging diseases, including cancer, rare diseases and autoimmune conditions. These advancements are due to the productivity of the United States’ biomedical R&D ecosystem, which is sustained by a policy framework designed to support and advance America’s leadership in the innovation of new medicines including strong intellectual property protections, a well-functioning, science-based regulatory system and coverage and payment policies that support and encourage medical innovation.
Glassboro, New Jersey - According to Rowan University, a Rowan University-affiliated startup whose innovation could dramatically improve the detection of brain tumors recently earned new grant funding from the New Jersey Commission on Science, Innovation and Technology (CSIT). MRIMath, LLC, was among 14 technology and life sciences companies to win a $25,000 grant through New Jersey’s Small Business Innovation Research Direct Financial Assistance Program. The grants are designed to help early-stage companies that have already earned awards from certain federal programs meant to bring U.S. innovations to the marketplace.
CSIT Now Accepting Applications for its Clean Tech R&D Voucher Program Program Connects Emerging Companies with Amenities at NJ Universities & Federal Laboratories
Trenton, New Jersey - According to the Commission on Science, Innovation and Technology (CSIT), it has reminded emerging companies within New Jersey’s clean energy sector that it is currently accepting applications for its Clean Tech Research and Development (R&D) Voucher Program. The application is available at https://application.njeda.com/csit.
The $435,000 program, funded through the New Jersey Board of Public Utilities (NJBPU), is designed to help early-stage New Jersey clean technology companies more easily access resources such as specialized equipment within the Garden State. CSIT developed the program in coordination with the NJBPU and the New Jersey Economic Development Authority (NJEDA).
NJEDA & digitalundivided Hold Instagram Live Chat to Showcase Resourcesfor Black & Latino Entrepreneurs
Trenton, New Jersey - According to the NJEDA, members of New Jersey’s innovation community had the opportunity to learn about public and private resources available to entrepreneurs of color during a “Removing Barriers for Diverse Entrepreneurs” Instagram Live discussion featuring New Jersey Economic Development Authority (NJEDA) Chief Executive Officer (CEO) Tim Sullivan and digitalundivided CEO Lauren Maillian. The chat also spotlighted the recently-proposed Black and Latino Seed Fund, which the NJEDA intends to create to drive capital to Black- and Latino-owned enterprises.
The innovation economy is facing a nationwide diversity crisis. According to Crunchbase, American companies raised a record-setting $150 billion in venture capital funding in 2020, but less than one percent of this went to Black-owned companies. The numbers are even worse for women. According to digitalundivided’s ProjectDiane, Black and Latina women received just 0.64 percent of total venture capital investment between 2018 and 2019.
Princeton, New Jersey - According to American Entrepreneurship.com, April 29th and 30th are now set for New Jersey Big Data Alliance’s 8th Annual Symposium that will showcase how New Jersey’s state, cities and communities are using big data to improve equity, sustainability and prosperity for the benefit of their community members.The free two event is open to the public who will hear opening remarks from: Dr. Peggy Brennan-Tonetta, President, NJBDA; Director, Resource and Economic Development, NJAES, Rutgers University Dr. Andrea Goldsmith, Dean, School of Engineering & Applied Science, Princeton University and Beth Noveck, Chief Innovation Officer, State of New Jersey.
BioNJ, New Jersey Health Care Quality Institute Release "Emerging From COVID-19: An Action Plan for a Healthier State"
Trenton/Princeton, New Jersey- According to the New Jersey Health Care Quality Institute and BioNJ, BioNJ, an advocate for the life sciences industry, and the New Jersey Health Care Quality Institute, a nonprofit health care improvement organization, today released an independent, far-reaching report designed to strengthen the state's health system in the wake of the COVID-19 pandemic.
The two organizations brought together experts from all sectors of the health care system to form the COVID 19 Work Group, which created "Emerging from COVID-19: An Action Plan for a Healthier State."
Rutgers Researchers Receive Award to Develop Rapid Sensor to Detect COVID-19 and Other Infectious Diseases within a Person’s Breath
DeMauro, Drazer, Lin and Javanmard Receive $443,000 NIH RADx-Rad award in Collaboration with Rutgers HealthAdvance™
A team of Rutgers researchers merged their ideas and technology with the support of research mentors to get the needed funds for developing a novel device capable of detecting the presence of viruses like SARS-CoV-2 in one’s breath.
U.S. Economic Development Administration Launches 2021 University Center Competition Eligible Universities in EDA’s Chicago and Philadelphia Regions Encouraged to Apply
The Economic Development Administration (EDA) is pleased to announce that it is now accepting applications under its FY 2021 University Center Economic Development Program competition. Open to accredited institutions of higher education or a consortium of accredited institutions of higher education in EDA’s Chicago and Philadelphia regions, EDA University Centers provide technical assistance to build regional economic ecosystems that support innovation and high-growth entrepreneurship, resiliency, and inclusiveness.
By Dean Paranicas, Health Care Institute of New Jersey
Morris Plains, New Jersey - According to ROI, biopharmaceutical and medical technology companies are true pillars of New Jersey’s economy and communities. With an overall economic impact of more than $83 billion (13% of New Jersey’s GDP) and more than 430,000 total life sciences-supported jobs in the state, they can be a catalyst for even greater economic growth — particularly for small business — which embraces far more entities than is usually understood by that term.
When policymakers and others talk about growing “small business,” they often refer to a stereotype that typically does not reflect the breadth of this critical cohort of New Jersey’s economy. In addition to Main Street shops, “mom-and-pop” businesses, coffeehouses and restaurants, “small business” includes professional services providers, equipment suppliers, maintenance contractors and others whose customers are other businesses rather than the general public.
Do not miss a single innovative moment and sign up for our newsletter!